<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A patient with congenital <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> and a history of <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> prior to pregnancy was successfully treated with subcutaneous <z:chebi fb="5" ids="28304">heparin</z:chebi> alone throughout two pregnancies </plain></SENT>
<SENT sid="1" pm="."><plain>Although adjuvant antithrombin III infusions may have a role in the treatment of this disorder, especially in the peripartum period, there is no evidence that this approach is superior to <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy alone </plain></SENT>
<SENT sid="2" pm="."><plain>We present this case as further evidence that <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy alone appears to be a safe and effective treatment for pregnant patients with this rare but serious disorder </plain></SENT>
</text></document>